BioSpace News Archive

Career Advice

How to Start Off On the Right Foot at a New Company

First impressions matter, and during your first few weeks at your new job, you’re laying the groundwork and establishing those key working relationships and processes that will set you up for success in the long run.

October 16, 2018
·
2 min read
·
Editorial Staff
Business

Taiho Pharmaceutical’s Venture Arm Increases Investment Pool to $300 Million

Taiho Ventures, the corporate venture capital arm of Taiho Pharmaceutical, has pumped up its venture capital pool from $50 million to $300 million. It also indicates it plans to accelerate its “open innovation” through the investments.

October 16, 2018
·
3 min read
·
Mark Terry
Policy

Amid Controversy in Drug Pricing on TV Ads, Biopharma Industry Argues Free Speech

“President Trump is taking historic action to bring patients more transparency through consumer advertising,” Azar said in a speech. “We are proposing to require American drug companies for the first time ever to include in their TV advertising the list prices of drugs paid for by Medicare or Medicaid.”

October 16, 2018
·
3 min read
·
Mark Terry
Drug Development

Listen up! Researchers Find Key to Regrowing Cells Related to Hearing Loss

Among life on earth, mammals are some of the only creatures that can’t regenerate damaged hearing. Birds, frogs, fish, they all have the ability to regenerate sensory hair cells after they’re damaged.

October 16, 2018
·
2 min read
·
Mark Terry
Business

The Perils and Promise of Partnerships Between Biopharma and Data Companies

Recently, 23andMe partnered with GlaxoSmithKline, causing the Forbes Technology Council to cite eight ways these types of partnerships will affect disease treatments. These types of partnerships aren’t exactly new.

October 16, 2018
·
4 min read
·
Mark Terry
Policy

Dissimilar to U.S. Market, Humira Biosimilar Competition Launches in Europe

AbbVie’s Humira is the world’s best-selling drug that generated more than $18 billion for the Illinois-based company last year. This week though, the company will begin to see challenges to Humira in Europe from biosimilars developed by Amgen and Novartis, as well as others.

October 16, 2018
·
2 min read
·
Alex Keown
Pharm Country

Companies Team up to Accelerate Market Readiness of Drug Development Programs

A new service offered by a pair of New York-based companies, H1 and Innovatively, is being touted as a tool that can help life science companies cut the time it takes to take a product through the clinic and into market in half.

October 16, 2018
·
3 min read
·
Alex Keown
WA Primary Health Alliance Focused on Improving Patient Experience by Asking Patients How They Feel

WA Primary Health Alliance (WAPHA) has recently implemented HappyOrNot, the smiley face customer satisfaction service, in selected general practices in Western Australia, giving patients a simple way to provide immediate feedback on a visit to their local GP.

October 16, 2018
·
3 min read
Drug Development

Five-Year Data Shows Novartis’ Cosentyx Safe and Effective in Treating Arthritis

New data from an ongoing late-stage study reinforced the safety and efficacy of Cosentyx (secukinumab) as a beneficial treatment for patients with psoriatic arthritis and ankylosing spondylitis.

October 16, 2018
·
2 min read
·
Alex Keown
Job Trends

Sanofi, Genentech Both Eye U.S. Expansions; Could Add up to 2,300 Jobs

Two well-established pharma companies are expanding in two different U.S. cities. One city is known for the plethora of pharma and biotech jobs, while the other is in an area that might not immediately spring to mind when it comes to biotech hubs.

October 16, 2018
·
2 min read
·
Alex Keown